The Boston-based biotech is axing Phase II plans for its only clinical-stage asset, in a bid to maximise shareholder value.

Epioxa by Glaukos Corp received US Food and Drug Administration (FDA) approval on 20 October as the first and only ...

As healthcare systems work towards new sustainability goals, medical textiles have become a key focus for innovation.

Mounjaro generated sales of $6.5bn in Q3 2025, up 109% from the same period in 2024. Zepbound exhibited even higher growth – ...

Swiss-based Debiopharm has formed a research partnership with South Korea-based AI drug discovery company NetTargets.

Helex has raised $3.5m in a seed funding round spearheaded by pi Ventures to advance non-viral gene therapies for kidney ...

Health Canada has issued a Notice of Compliance (NOC) for AstraZeneca’s HER2-directed antibody drug conjugate (ADC) Enhertu.

The FDA's draft guidance is supposed to cut the cost and time-associated burden of biosimilar development, despite a mixed ...

With tighter regulations around biopharma manufacturing and the emergence of advanced therapies, cleanroom design is being ...

While Pfizer called the bid “reckless”, Metsera disagrees, stating that it will review the “superior proposal”.

Eli Lilly will invest over $1.2bn into its manufacturing site in Puerto Rico, as it aims to assemble a robust supply chain ...

Dewpoint Therapeutics has received the US FDA's ODD for DPTX3186, a small-molecule condensate modulator for treating gastric ...